Bjarne Bach Pedersen

Rituximab in chronic cold agglutinin disease: a prospective study of 20 patients

Claudia Schöllkopf, Lars Kjeldsen, Ole Weiss Bjerrum et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2005 · 174 citations

Life Sciences, Hematology, Immunology +14

Rituximab chimeric anti‐CD20 monoclonal antibody treatment for adult refractory idiopathic thrombocytopenic purpura

Peter Brændstrup, Ole Weis Bjerrum, Ove Juul Nielsen et al. · American Journal of Hematology · 2005 · 135 citations

Life Sciences, Hematology, Immunology +17

R-CHOEP-14 improves overall survival in young high-risk patients with diffuse large B-cell lymphoma compared with R-CHOP-14. A population-based investigation from the Danish Lymphoma Group

Anne Ortved Gang, Camilla Strøm, Mette Ølgod Pedersen et al. · Annals of Oncology · 2011 · 76 citations · Full text

Medicine, Hematology, Oncology +5

Reasons for treating secondary AML as <i>de novo</i> AML

Lene Sofie Granfeldt Østgård, Eigil Kjeldsen, Mette Skov Holm et al. · European Journal Of Haematology · 2010 · 57 citations

Medicine, Hematology, Oncology +13

Recurrent genomic imbalances in B-cell splenic marginal-zone lymphoma revealed by comparative genomic hybridization

Claus L. Andersen, Alicja Gruszka, Shayne Atkinson et al. · Cancer Genetics and Cytogenetics · 2005 · 33 citations

Life Sciences, Genetics, Oncology +16